Millicent Drug Patent Portfolio
Millicent owns 1 orange book drug protected by 3 US patents Given below is the list of Millicent's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8268806 | Pharmaceutical compositions | 19 Mar, 2031 | Active |
| US8957054 | Pharmaceutical compositions | 08 Jan, 2030 | Active |
| US8629129 | Pharmaceutical compositions | 07 Aug, 2028 | Active |
Latest Legal Activities on Millicent's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Millicent.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 06 Feb, 2024 | US8268806 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Jul, 2022 | US8957054 |
|
Withdrawal of Application for PTE
Critical
| 20 Apr, 2022 | US8629129 |
|
Patent Term Extension Certificate
Critical
| 19 Apr, 2022 | US8957054 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 29 Apr, 2021 | US8629129 |
| Notice of Final Determination -Election Required | 12 Mar, 2021 | US8957054 |
| Notice of Final Determination -Election Required | 12 Mar, 2021 | US8629129 |
|
FDA Final Eligibility Letter
Critical
| 13 Oct, 2020 | US8957054 |
|
FDA Final Eligibility Letter
Critical
| 13 Oct, 2020 | US8629129 |
| transaction for FDA Determination of Regulatory Review Period | 20 Feb, 2020 | US8629129 |
| transaction for FDA Determination of Regulatory Review Period | 20 Feb, 2020 | US8957054 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 26 Nov, 2019 | US8268806 |
|
Correspondence Address Change
Critical
| 28 Jan, 2019 | US8957054 |
|
Correspondence Address Change
Critical
| 28 Jan, 2019 | US8629129 |
| Second letter to regulating agency to determine regulatory review period | 09 Jan, 2019 | US8629129 |
Millicent's Family Patents
Millicent Drug List
Given below is the complete list of Millicent's drugs and the patents protecting them.
1. Intrarosa
Intrarosa is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8268806 | Pharmaceutical compositions |
19 Mar, 2031
(6 years from now)
| Active |
| US8957054 | Pharmaceutical compositions |
08 Jan, 2030
(4 years from now)
| Active |
| US8629129 | Pharmaceutical compositions |
07 Aug, 2028
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Intrarosa's drug page